PriceTarget Research
  • Home
  • Videos
  • Rating Reports
  • Scorecards
  • Alerts
  • Our Stock Rankings
  • About Us
  • Contact Us
HomeexchangesNASDAQ

exchange: NASDAQ

New Earnings

Alert: New Earnings Report (1/12/24)-Unity Bancorp Inc (NASDAQ: UNTY).

January 12, 2024 John Lafferty 0

Unity Bancorp Inc (NASDAQ: UNTY) has reported E.P.S. of $0.97 for its fourth fiscal quarter (ending December 31) versus $0.94 for the same period a year ago — an increase of 3%. This performance was […]

Negative

Alert: Negative Investment/Fundamental Signals (1/12/24)-Netease Inc (NASDAQ: NTES)

January 12, 2024 John Lafferty 0

Netease Inc (NASDAQ: NTES) has recently experienced meaningful negative changes in fundamentals: significant quarterly sales deceleration occurred, the consensus estimate for December, 2023 decreased significantly, and the consensus estimate for December, 2024 decreased significantly. Recent […]

Up

Alert: Rating Upgrade (1/12/24)-Neurocrine Biosciences Inc (NASDAQ: NBIX).

January 12, 2024 John Lafferty 0

Stock Rating Upgrade Reflecting improving fundamentals and high Appreciation Potential, the Value Trend Rating for Neurocrine Biosciences Inc (NASDAQ: NBIX) improved of late. NBIX’s current Value Trend Rating is B and the prior Rating was […]

Down

Alert: Rating Downgrade (1/12/24)-Fate Therapeutics Inc (NASDAQ: FATE).

January 12, 2024 John Lafferty 0

Stock Rating Downgrade The Value Trend Rating for Fate Therapeutics Inc (NASDAQ: FATE) weakened recently from C to D reflecting eroding fundamentals and low Appreciation Potential. Details supporting this lower rating are included in our […]

Price Chg

Alert: Major Price Advance (1/12/24)-Flexsteel Industries Inc (NASDAQ: FLXS).

January 12, 2024 John Lafferty 0

On 1/12/24, Flexsteel Industries Inc (NASDAQ: FLXS) stock enjoyed a major increase of 29.2%, closing at $23.28. Moreover, exceptionally high trading volume at 848% of normal accompanied the advance. Relative to the market the stock […]

Price Chg

Alert: Major Price Advance (1/12/24)-EyePoint Pharmaceuticals Inc (NASDAQ: EYPT).

January 12, 2024 John Lafferty 0

EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) stock closed at $22.76 on 1/12/24 after a major increase of 11.8%. However, this advance was accompanied by below average trading volume at 81% of normal. The stock has been […]

Negative

Alert: Negative Investment/Fundamental Signals (1/12/24)-Netease Inc (NASDAQ: NTES)

January 12, 2024 John Lafferty 0

Netease Inc (NASDAQ: NTES) has recently experienced meaningful negative changes in fundamentals: significant quarterly sales deceleration occurred, the consensus estimate for December, 2023 decreased significantly, and the consensus estimate for December, 2024 decreased significantly. Recent […]

signals-pos

Alert: Positive Investment/Fundamental Signals (1/12/24)-CF Bankshares Inc (NASDAQ: CFBK)

January 12, 2024 John Lafferty 0

Extremely significant positive changes in CF Bankshares Inc (NASDAQ: CFBK) investment behavior have recently occurred: positive upside/downside volume developed, and its longer term price trend turned up. Important positive changes in CF Bankshares Inc (NASDAQ: […]

Up

Alert: Rating Upgrade (1/12/24)-Plug Power Inc (NASDAQ: PLUG).

January 12, 2024 John Lafferty 0

Stock Rating Upgrade The Value Trend Rating for Plug Power Inc (NASDAQ: PLUG) improved recently from D to C reflecting improving fundamentals and high Appreciation Potential. Details supporting this higher rating are included in our […]

Down

Alert: Rating Downgrade (1/12/24)-Sarepta Therapeutics Inc (NASDAQ: SRPT).

January 12, 2024 John Lafferty 0

Stock Rating Downgrade The Value Trend Rating for Sarepta Therapeutics Inc (NASDAQ: SRPT) weakened of late from C to D reflecting eroding fundamentals and low Appreciation Potential. Details supporting this lower rating are included in […]

Posts navigation

« 1 … 831 832 833 … 961 »

Search

Ratings

  • A
  • B
  • C
  • D
  • F

Exchanges

  • NASDAQ
  • NYSE
  • NYSEAMERICAN
  • CVE
  • BATS
  • TSE
  • NYSEARCA

Industries

Sectors

Privacy Statement Terms Of Use ©2024 PriceTarget Research